I participated in the Doctoring Up Your Social Media Advocacy panel at #SXSW on Monday, March 13, 2017. These were my introductory slides with background on Mayo Clinic's social media program.
I participated in the Doctoring Up Your Social Media Advocacy panel at #SXSW on Monday, March 13, 2017. These were my introductory slides with background on Mayo Clinic's social media program.
Leveraging the Latest Social Tools and Networks to Enhance Clinical Trial Rec...Lee Aase
Slides from my joint presentation with Julia Thebiay on July 21, 2016 in Denver at the Society for Clinical Research Associates conference on social media.
Slides for a two-hour workshop I presenting on Thursday, March 6, 2014. Examples of Twitter gaffes and controversies, as well as step-by-step training in setting up a new Twitter account, and some positive applications of Twitter in a business context.
My HealthFinder. org SWSX slideshare demodeborahvd8
This is an overview of MyHealthFinder.org a mobile website (also available as iOS and Android apps). A trusted community-enabled tool for locating and rating community health resources
The Evolution of the Online Physician Profile@chrisboyer LLC
Over the past few years, there has been a landslide of new opportunities for physicians to promote themselves online. But with all of these new websites, new tools and new methods, one thing remains true: it’s tremendously important for doctors practicing medicine today to be found online. But how can your organization make sense of this all? This presentation will help hospitals and doctors understand the most important things physicians practicing today need to address, and provide some tested and true ways to build alignment between healthcare organizations and physicians, to ensure they are winning the battle of online reputation.
Ohio State Medical Center Social Media April 2011Ryan Squire
Presentation to Ohio State University Medical Center Senior Leaders about social media and the change that we are driving. The event is #MCSLR or the Medical Center senior leader retreat that focused on change.
Leveraging the Latest Social Tools and Networks to Enhance Clinical Trial Rec...Lee Aase
Slides from my joint presentation with Julia Thebiay on July 21, 2016 in Denver at the Society for Clinical Research Associates conference on social media.
Slides for a two-hour workshop I presenting on Thursday, March 6, 2014. Examples of Twitter gaffes and controversies, as well as step-by-step training in setting up a new Twitter account, and some positive applications of Twitter in a business context.
My HealthFinder. org SWSX slideshare demodeborahvd8
This is an overview of MyHealthFinder.org a mobile website (also available as iOS and Android apps). A trusted community-enabled tool for locating and rating community health resources
The Evolution of the Online Physician Profile@chrisboyer LLC
Over the past few years, there has been a landslide of new opportunities for physicians to promote themselves online. But with all of these new websites, new tools and new methods, one thing remains true: it’s tremendously important for doctors practicing medicine today to be found online. But how can your organization make sense of this all? This presentation will help hospitals and doctors understand the most important things physicians practicing today need to address, and provide some tested and true ways to build alignment between healthcare organizations and physicians, to ensure they are winning the battle of online reputation.
Ohio State Medical Center Social Media April 2011Ryan Squire
Presentation to Ohio State University Medical Center Senior Leaders about social media and the change that we are driving. The event is #MCSLR or the Medical Center senior leader retreat that focused on change.
This Entrada Group (www.entradagroup.com) presentation charts the evolution and advantages of shelter services in Mexico, which have been developed to help manufacturers serve key markets in North America.
Trends in Nearshore and Offshore ManufacturingEntrada Group
This Entrada Group (www.entradagroup.com) presentation explains why and how Mexico is becoming a key manufacturing destination for the world’s aerospace industry.
My presentation to a conference called "An Executive Perspective on Social Media" presented by the Social Media Research Lab at Michigan State University.
Social Media The Evolving Patient Physician Connection FinalStephanie Cannon
Getting physicians to recognize, and embrace, the shift to social media may not be easy. Examine proven examples of how social media can be used to strengthen patient and physician interactions, the value of different outlets, and tactics for obtaining buy-in from physicians and other staff.
Stephanie Cannon
Director, Web Communications & eBusiness
Nationwide Children’s Hospital (Columbus, OH)
Elizabeth Scott
President & Principal Consultant
Raven New Media & Marketing, LLC
My presentation to a group of Continuing Medical Education (CME) professionals about Mayo Clinic's social media experience and how it relates to CME. For more information on our Center for Social Media, go to http://socialmedia.mayoclinic.org/
Why does Mayo Clinic engage in Social MediaVictor Montori
Presentation for Doctors 2.0 and You conference in Paris, June 2011 - Presented by Victor Montori (@vmontori), medical director of Mayo Clinic Center for Social Media (#MCCSM)
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae